Drugs Made In America Acquisition Corp. (DMAA:NASDAQ) closed at $10.90 on November 17, 2026, unchanged on the day. The stock trades 0.1% below its 52-week high of $10.91 and 5.6% above its 52-week low of $10.32. Over the past year, it gained 5.5%. Drugs Made In America Acquisition Corp. is part of the Funds & Shells sector.
In 252 trading sessions since November 17, 2025, DMAA closed higher on 95 days (38%). Its best day was March 20, 2026 (+0.48%) and its worst was October 7, 2026 (-0.46%). It never moved 10% or more in a single session.
Find more stocks like DMAA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.